Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.

Correction: Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.

Bibliographic Details
Main Authors:	Fengchen Liu, Travis C Porco, Abdou Amza, Boubacar Kadri, Baido Nassirou, Sheila K West, Robin L Bailey, Jeremy D Keenan, Anthony W Solomon, Paul M Emerson, Manoj Gambhir, Thomas M Lietman
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-09-01
Series:	PLoS Neglected Tropical Diseases
Online Access:	http://europepmc.org/articles/PMC4587743?pdf=render

Similar Items

Short-term Forecasting of the Prevalence of Trachoma: Expert Opinion, Statistical Regression, versus Transmission Models.
by: Fengchen Liu, et al.
Published: (2015-08-01)

Short-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infection
by: Fengchen Liu, et al.
Published: (2015-10-01)

Community-level chlamydial serology for assessing trachoma elimination in trachoma-endemic Niger.
by: Jessica S Kim, et al.
Published: (2019-01-01)

The easiest children to reach are most likely to be infected with ocular Chlamydia trachomatis in trachoma endemic areas of Niger.
by: Abdou Amza, et al.
Published: (2013-01-01)

Probabilistic forecasts of trachoma transmission at the district level: A statistical model comparison
by: Amy Pinsent, et al.
Published: (2017-03-01)

The distribution of the prevalence of ocular chlamydial infection in communities where trachoma is disappearing
by: Thomas M. Lietman, et al.
Published: (2015-06-01)

Does mass azithromycin distribution impact child growth and nutrition in Niger? A cluster-randomized trial.
by: Abdou Amza, et al.
Published: (2014-09-01)

Azithromycin Reduction to Reach Elimination of Trachoma (ARRET): study protocol for a cluster randomized trial of stopping mass azithromycin distribution for trachoma
by: Abdou Amza, et al.
Published: (2021-01-01)

Assessment of transmission in trachoma programs over time suggests no short-term loss of immunity.
by: Fengchen Liu, et al.
Published: (2013-01-01)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
by: Fengchen Liu, et al.
Published: (2014-03-01)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity
by: Fengchen Liu, et al.
Published: (2013-07-01)

Correction: Assessment of Transmission in Trachoma Programs over Time Suggests No Short-Term Loss of Immunity.
by: Fengchen Liu, et al.
Published: (2013-07-01)

The distribution of ocular Chlamydia prevalence across Tanzanian communities where trachoma is declining.
by: Salman A Rahman, et al.
Published: (2015-03-01)

Correction: The Distribution of Ocular Chlamydia Prevalence across Tanzanian Communities Where Trachoma Is Declining.
by: Salman A Rahman, et al.
Published: (2015-05-01)

Sensitivity and specificity of computer vision classification of eyelid photographs for programmatic trachoma assessment.
by: Matthew C Kim, et al.
Published: (2019-01-01)

Monitoring transmission intensity of trachoma with serology
by: Christine Tedijanto, et al.
Published: (2023-06-01)

Identifying a sufficient core group for trachoma transmission.
by: Thomas M Lietman, et al.
Published: (2018-10-01)

The SAFE strategy for the elimination of trachoma by 2020: will it work?
by: Robin Bailey, et al.

The SAFE strategy for the elimination of trachoma by 2020: will it work?
by: Bailey Robin, et al.
Published: (2001-01-01)

Short-term leprosy forecasting from an expert opinion survey.
by: Michael S Deiner, et al.
Published: (2017-01-01)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
by: Catherine E. Oldenburg, et al.
Published: (2019-12-01)

Targeting antibiotics to households for trachoma control.
by: Isobel M Blake, et al.
Published: (2010-11-01)

Correction: Short-term leprosy forecasting from an expert opinion survey.
by: Michael S Deiner, et al.
Published: (2017-01-01)

When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.
by: Kathryn J Ray, et al.
Published: (2009-06-01)

Elimination and eradication of neglected tropical diseases with mass drug administrations: a survey of experts.
by: Jeremy D Keenan, et al.
Published: (2013-01-01)

Models of trachoma transmission and their policy implications: From control to elimination
by: Lietman, T, et al.
Published: (2018)

Stopping azithromycin mass drug administration for trachoma: A systematic review.
by: Hamidah Mahmud, et al.
Published: (2021-07-01)

Implications of the COVID-19 pandemic in eliminating trachoma as a public health problem
by: Blumberg, S, et al.
Published: (2021)

Forecasting trachoma control and identifying transmission-hotspots
by: Blumberg, S, et al.
Published: (2021)

Trachoma prevalence after discontinuation of mass azithromycin distribution
by: Godwin, W, et al.
Published: (2020)

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial.
by: Jeremy D Keenan, et al.
Published: (2019-06-01)

Costs of testing for ocular Chlamydia trachomatis infection compared to mass drug administration for trachoma in the Gambia: application of results from the PRET study.
by: Emma Harding-Esch, et al.
Published: (2015-04-01)

The distribution of district-level leprosy incidence in India is geometric-stable, consistent with subcriticality
by: Thomas M. Lietman, et al.
Published: (2018-09-01)

The SAFE strategy for trachoma control: using operational research for policy, planning and implementation
by: Emerson Paul M, et al.
Published: (2006-01-01)

Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution.
by: Takele Lakew, et al.
Published: (2009-08-01)

Modelling trachoma post-2020: opportunities for mitigating the impact of COVID-19 and accelerating progress towards elimination
by: Borlase, A, et al.
Published: (2021)

Improving our forecasts for trachoma elimination: What else do we need to know?
by: Amy Pinsent, et al.
Published: (2017-02-01)

Mass azithromycin distribution for hyperendemic trachoma following a cluster-randomized trial: A continuation study of randomly reassigned subclusters (TANA II).
by: Jeremy D Keenan, et al.
Published: (2018-08-01)

Possible changes in the transmissibility of trachoma following MDA and transmission reduction: implications for the GET2020 goals
by: Manoj Gambhir, et al.
Published: (2015-10-01)

The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control.
by: Manoj Gambhir, et al.
Published: (2009-06-01)